Ingevity Corporation
NGVT
$52.23
$0.060.12%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -7.43% | -14.69% | -28.06% | -26.98% | -23.21% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -7.43% | -14.69% | -28.06% | -26.98% | -23.21% |
| Cost of Revenue | -14.99% | -25.39% | -41.76% | -37.00% | -27.61% |
| Gross Profit | 6.97% | 8.85% | 6.96% | -2.50% | -13.15% |
| SG&A Expenses | 3.49% | -1.57% | -15.28% | -13.70% | -16.61% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -11.45% | -21.38% | -37.71% | -33.60% | -25.93% |
| Operating Income | 8.62% | 16.35% | 26.04% | 7.03% | -9.99% |
| Income Before Tax | 91.24% | 89.40% | 60.92% | -1,442.57% | -294.74% |
| Income Tax Expenses | 144.41% | 120.03% | 72.94% | -568.09% | -266.12% |
| Earnings from Continuing Operations | 78.70% | 82.79% | 57.27% | -2,203.70% | -302.99% |
| Earnings from Discontinued Operations | 101.75% | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 88.31% | 49.78% | -215.61% | -7,868.52% | -543.86% |
| EBIT | 8.62% | 16.35% | 26.04% | 7.03% | -9.99% |
| EBITDA | 3.41% | 7.46% | 14.08% | 3.11% | -7.57% |
| EPS Basic | 88.39% | 49.94% | -214.38% | -6,110.85% | -549.90% |
| Normalized Basic EPS | 14.95% | 25.62% | 89.61% | 10.34% | -14.84% |
| EPS Diluted | 88.19% | 50.04% | -212.50% | -5,225.31% | -553.34% |
| Normalized Diluted EPS | 14.31% | 25.47% | 89.92% | 10.74% | -14.39% |
| Average Basic Shares Outstanding | 0.21% | 0.32% | 0.18% | -0.52% | -1.40% |
| Average Diluted Shares Outstanding | 0.95% | 0.71% | 0.42% | -0.73% | -2.01% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |